School of Medicine
Showing 251-260 of 536 Results
-
Jonathan Z. Long
Associate Professor of Pathology
BioDr. Jonathan Long is an Associate Professor of Pathology and an Institute Scholar of Stanford ChEM-H (Chemistry, Engineering & Medicine for Human Health). His laboratory studies signaling pathways in mammalian energy metabolism. The long-term goal of this program is to discover new molecules and pathways that can be translated into therapeutic opportunities for obesity, metabolic disease, and other age-associated chronic diseases. Work from the laboratory has been recognized by numerous awards from the Alfred P. Sloan Foundation, the National Institutes of Health, the American Diabetes Association, and the Ono Pharma Foundation. Prior to arriving to Stanford, Dr. Long completed his Ph.D. in Chemistry at Scripps Research and his postdoctoral work at Harvard Medical School.
-
Teri A Longacre
Richard L. Kempson, MD, Professor in Surgical Pathology
Current Research and Scholarly InterestsGynecological, breast and gastrointestinal pathology with major emphasis on ovarian cancer and ovarian tumors of low malignant potential. Pathology of familial and hereditary breast-ovarian-GI cancer.
-
Alarice Cheng-Yi Lowe
Associate Professor of Pathology
BioDr. Lowe joined the School of Medicine faculty in 2019. She received her undergraduate degree in Biology from MIT and her medical degree at UCSD, prior to residency and cytology fellowship at UCLA. In 2011, she joined the faculty at Brigham and Women's Hospital where she developed a research focus on Circulating Tumor Cells (CTCs) and the application of new technology to improve clinical and molecular diagnostics. Clinically, her interests focus on Cytopathology and Genitourinary Pathology.
-
Bingwei Lu
Professor of Pathology
Current Research and Scholarly InterestsWe are interested in understanding how neural stem cells balance their self-renewal and differentiation and how deregulation of this process can result in brain tumor. We are also interested in mechanisms of neurodegeneration in Alzheimers and Parkinsons diseases. We are using both Drosophila and mammalian models to address these fundamental questions.
-
Emma Lundberg
Associate Professor of Bioengineering and of Pathology
BioDr. Emma Lundberg is an Associate Professor of Bioengineering and Pathology at Stanford University and serves at the Director of the Cell Atlas of the Human Protein Atlas initiative in Sweden, where she is also Professor at KTH Royal Institute of Technology. At the intersection of bioimaging, proteomics, and artificial intelligence, her research aims to define the spatiotemporal organization of the human proteome at both cellular and subcellular level. Dr. Lundberg aims to develop integrated models of human cells to elucidate how variations in protein localization patterns influence cellular function, ultimately enabling the simulation of cell behavior and a systems-level understanding of how biological information is spatially encoded. The Lundberg Lab is responsible for creating the Subcellular Atlas of the Human Protein Atlas database (https://www.proteinatlas.org/). Dr. Lundberg is dedicated to building virtual cell models to simulate cell behavior, and is passionate about engaging the public in her work through citizen science games and computational challenges.
Dr. Lundberg holds a Master’s degree in Bioengineering and a PhD in Biotechnology from KTH Royal Institute of Technology in Sweden. She has served as Secretary General of the Human Proteome Organization, and is actively involved in advisory roles for numerous open-access databases and cell mapping efforts such as the CZI AI Virtual Cell, Human Cell Atlas consortium, UniProt db, Reactome db, Human Proteome Project and various pharma and biotech companies. As a token of her leadership skills and advocate for open science, she was twice recognized as top 10 under 40 for future leaders in biopharma and omics.
